Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
15.67
-0.04 (-0.25%)
Mar 26, 2026, 4:00 PM EDT - Market closed
Monte Rosa Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$32.00
Upside
+104.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $34 → $30 | Strong Buy | Maintains | $34 → $30 | +91.45% | Mar 18, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $30 → $29 | Buy | Maintains | $30 → $29 | +85.07% | Mar 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $28 → $37 | Buy | Reiterates | $28 → $37 | +136.12% | Jan 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $22 → $30 | Buy | Maintains | $22 → $30 | +91.45% | Jan 8, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $16 → $34 | Strong Buy | Maintains | $16 → $34 | +116.98% | Jan 8, 2026 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $13 → $22 | Hold → Buy | Upgrades | $13 → $22 | +40.40% | Dec 16, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $10 → $13 | Hold | Maintains | $10 → $13 | -17.04% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | -36.18% | Mar 21, 2025 |
| Wedbush | Wedbush | Buy Maintains $15 → $17 | Buy | Maintains | $15 → $17 | +8.49% | Mar 21, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $14 → $11 | Buy → Hold | Downgrades | $14 → $11 | -29.80% | Dec 19, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $14 | Buy | Maintains | $17 → $14 | -10.66% | Nov 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | -29.80% | Sep 12, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +8.49% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $16 | Buy | Reiterates | $16 | +2.11% | Jun 28, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | -29.80% | May 22, 2024 |
| Wedbush | Wedbush | Buy Initiates $11 | Buy | Initiates | $11 | -29.80% | Feb 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.